These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 8641298)

  • 41. Varicella vaccination in the immunocompromised.
    Malaiya R; Patel S; Snowden N; Leventis P
    Rheumatology (Oxford); 2015 Apr; 54(4):567-9. PubMed ID: 24758889
    [No Abstract]   [Full Text] [Related]  

  • 42. Vaccination to prevent varicella.
    Myers MG
    Vaccine; 2013 Mar; 31(13):1695. PubMed ID: 23164797
    [No Abstract]   [Full Text] [Related]  

  • 43. [Herpes zoster and its prevention].
    Kamiya H; Asano Y; Shiraki K; Nakano T; Higa K
    Kansenshogaku Zasshi; 2010 Nov; 84(6):694-701. PubMed ID: 21226320
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Herpes zoster-related hospitalizations and expenditures before and after introduction of the varicella vaccine in the United States.
    Patel MS; Gebremariam A; Davis MM
    Infect Control Hosp Epidemiol; 2008 Dec; 29(12):1157-63. PubMed ID: 18999945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Comments on vaccines, August 1987.
    Wheeler CE
    J Am Acad Dermatol; 1988 Jan; 18(1 Pt 2):232-4. PubMed ID: 3339145
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Influence of demographic changes on the impact of vaccination against varicella and herpes zoster in Germany - a mathematical modelling study.
    Horn J; Damm O; Greiner W; Hengel H; Kretzschmar ME; Siedler A; Ultsch B; Weidemann F; Wichmann O; Karch A; Mikolajczyk RT
    BMC Med; 2018 Jan; 16(1):3. PubMed ID: 29316913
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Incidence of herpes zoster in pediatricians and history of reexposure to varicella-zoster virus in patients with herpes zoster].
    Terada K; Hiraga Y; Kawano S; Kataoka N
    Kansenshogaku Zasshi; 1995 Aug; 69(8):908-12. PubMed ID: 7594784
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differences in antibody responses in varicella, herpes zoster and after vaccination.
    Kimoto T; Kurimura T
    Arch Virol; 1979; 59(1-2):59-67. PubMed ID: 218537
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response.
    Brunell PA; Novelli VM; Keller PM; Ellis RW
    J Infect Dis; 1987 Sep; 156(3):430-5. PubMed ID: 3039010
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevention strategies: herpes zoster, post-herpetic neuralgia and immunogenicity.
    Levin MJ; Schmader K
    Herpes; 2007 Sep; 14 Suppl 2():45-7. PubMed ID: 17939896
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Varicella-zoster virus vaccine, successes and difficulties.
    Sarkadi J
    Acta Microbiol Immunol Hung; 2013 Dec; 60(4):379-96. PubMed ID: 24292083
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Chickenpox vaccines: new drugs. A favourable risk-benefit balance in some situations.
    Prescrire Int; 2005 Jun; 14(77):85-91. PubMed ID: 15977369
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The effect of vaccination on the epidemiology of varicella zoster virus.
    Edmunds WJ; Brisson M
    J Infect; 2002 May; 44(4):211-9. PubMed ID: 12099726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Varicella zoster infection in adults: a preventable disease.
    Megged O; Schlesinger Y
    Isr Med Assoc J; 2009 May; 11(5):306-7. PubMed ID: 19637510
    [No Abstract]   [Full Text] [Related]  

  • 55. [Varicella-zoster virus infections. 1: Chickenpox and shingles. Treatment and prevention].
    Wassilew SW
    MMW Fortschr Med; 2006; Spec no.1():1-5; quiz 6. PubMed ID: 16872125
    [No Abstract]   [Full Text] [Related]  

  • 56. [Management of herpes zoster infection].
    Lauhio A; Anttila VJ
    Duodecim; 2009; 125(15):1608-14. PubMed ID: 19769176
    [TBL] [Abstract][Full Text] [Related]  

  • 57. General vaccination of children against varicella?--Yes!
    Trollfors B
    Acta Paediatr; 2007 Jun; 96(6):794-5. PubMed ID: 17537004
    [No Abstract]   [Full Text] [Related]  

  • 58. Herpes Zoster Vaccination: Controversies and Common Clinical Questions.
    Van Epps P; Schmader KE; Canaday DH
    Gerontology; 2016; 62(2):150-4. PubMed ID: 26184711
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical trial of live attenuated Varicella vaccine in high risk susceptibles--a preliminary report.
    Gershon AA; Steinberg S; Borkowsky W
    Dev Biol Stand; 1982; 52():391-7. PubMed ID: 6299849
    [No Abstract]   [Full Text] [Related]  

  • 60. Varicella zoster virus vaccination policies and surveillance strategies in Europe.
    Pinot de Moira A; Nardone A;
    Euro Surveill; 2005 Jan; 10(1):43-5. PubMed ID: 15701939
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.